Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status (Q44195519)
Jump to navigation
Jump to search
scientific article published in January 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status |
scientific article published in January 2002 |
Statements
1 reference
Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status (English)
1 reference
Martin H Cohen
1 reference
Marie L Moses
1 reference
Richard Pazdur
1 reference
1 January 2002
1 reference
1 reference
7
1 reference
5
1 reference
390-392
1 reference
Identifiers
1 reference
1 reference